If HRT was known to be a safe treatment for all future potential diseases stated, I don't think it would be down to cost factors, it would save the NHS a fortune to prevent such diseases happening therefore one would think, make HRT a preventative treatment. I have always wondered why there is still such a stigma because there always has been when it comes to systemic HRT and why I always call it a minefield.
I found this AI answer whilst researching the subject of why HRT is not used as a preventative treatment.
Hormone Replacement Therapy (HRT) is not used as a preventive treatment for chronic conditions because large-scale clinical trials have found the potential harms often outweigh the benefits for asymptomatic women. While HRT can offer some benefits, its use is primarily recommended for the short-term management of severe menopausal symptoms and for osteoporosis prevention in high-risk cases.
Primary Concerns and Risks
Major health organizations, including the U.S. Preventive Services Task Force (USPSTF) and the American Heart Association, advise against using HRT for the sole purpose of preventing chronic diseases due to the associated risks. These risks include:
• Blood Clots and Stroke: Oral HRT, in particular, increases the risk of venous thromboembolism (VTE), deep vein thrombosis, pulmonary embolism, and stroke.
• Cardiovascular Events: Studies, most notably the Women's Health Initiative (WHI) trial, did not find a net benefit for cardiovascular disease prevention and, in some cases, found an increased risk of heart attack and coronary heart disease events, especially when initiated in older women or those more than 10 years past menopause onset.
• Cancer Risk:
o Breast Cancer: Combined estrogen and progestin therapy is associated with a small, increased risk of breast cancer, which rises with the duration of use.
o Ovarian Cancer: There is an increased, though low, risk of ovarian cancer with both combined and estrogen-only HRT.
o Endometrial (Uterine) Cancer: Estrogen-only therapy significantly increases the risk of endometrial cancer, which is why a progestin is added for women who still have a uterus.
Shifting Perspectives and Individualized Care
The current medical consensus emphasizes an individualized approach to HRT based on a woman's age, specific symptoms, and personal risk factors.
• Focus on Symptom Relief: HRT is considered the most effective treatment for moderate to severe menopausal symptoms like hot flashes and vaginal dryness, and the benefits usually outweigh the risks for healthy women under 60 years old or within 10 years of menopause.
• Risk Mitigation: Certain formulations and delivery methods can mitigate some risks. For example, transdermal patches, gels, or sprays generally do not carry the same risk of blood clots or stroke as oral tablets because they bypass the liver's initial metabolism.
• Alternative Preventive Measures: For chronic disease prevention, healthcare providers recommend focusing on lifestyle modifications, such as a healthy diet, regular exercise, not smoking, and managing other risk factors with proven therapies (e.g., bisphosphonates for osteoporosis, statins for high cholesterol).
Ultimately, the decision to use HRT is a personal one that should be made after a thorough discussion of the pros and cons with a healthcare provider.